Skip to main content
. Author manuscript; available in PMC: 2021 Jun 10.
Published in final edited form as: N Engl J Med. 2021 Jun 10;384(23):2177–2186. doi: 10.1056/NEJMoa2030243

Figure 3: Cluster randomisation, participant enrolment, inclusion in analysis dataset, and follow-up of safety endpoints.

Figure 3:

The commonest reasons for exclusion from the analysis dataset were enrolment before the predefined time point of Wolbachia establishment (8th January 2018), enrolment in a calendar month without any VCD cases (September 2018) or having positive or equivocal dengue IgM or IgG serology at enrolment that precluded classification as a test-negative control.